GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
C

Community Health Systems CYH · USD

Health Care · US listing · 🇺🇸 United States

Compare

2.26

+2.26%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in USD, from our data supplier.

FY2025

Revenue

$12.48bn

FY2016FY2025

Net income

$509.0m

FY2016FY2025

Free cash flow

$208.0m

FY2016FY2025

Shareholders' equity

−$1.39bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue$12.48bn$12.63bn$12.49bn$12.21bn$12.37bn$11.79bn$13.21bn$14.15bn$15.35bn$18.44bn
Research and development——$80.0m$85.0m$108.0m—————
Operating income$1.59bn$542.0m$957.0m$821.0m$1.38bn$1.45bn$650.0m$208.0m−$1.90bn−$860.0m
Net income$509.0m−$516.0m−$133.0m$46.0m$230.0m$511.0m−$590.0m−$788.0m−$2.46bn−$1.72bn
Diluted earnings per share3.77-3.91-1.010.351.734.22-5.18-6.97-21.96-15.50

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assets$13.20bn$14.05bn$14.46bn$14.67bn$15.22bn$16.01bn$15.61bn$15.86bn$17.45bn$21.94bn
Cash and short-term investments$260.0m$37.0m$38.0m$118.0m$507.0m$1.68bn$216.0m$196.0m$563.0m$238.0m
Total liabilities$14.04bn$15.37bn$15.28bn$15.40bn$16.03bn$17.06bn$17.25bn$16.82bn$17.61bn$19.66bn
Debt$10.40bn$11.45bn$11.49bn$11.63bn$12.14bn$12.22bn$13.40bn$13.60bn$13.91bn$15.24bn
Shareholders' equity−$1.39bn−$1.91bn−$1.39bn−$1.37bn−$1.37bn−$1.63bn−$2.22bn−$1.53bn−$767.0m$1.61bn
Shares outstanding135m132m132m130m133m121m114m113m112m111m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations$543.0m$480.0m$210.0m$300.0m−$131.0m$2.18bn$385.0m$274.0m$773.0m$1.14bn
Capital spending−$335.0m−$360.0m−$467.0m−$415.0m−$469.0m−$440.0m−$438.0m−$527.0m−$570.0m−$867.0m
Free cash flow$208.0m$120.0m−$257.0m−$115.0m−$600.0m$1.74bn−$53.0m−$253.0m$203.0m$270.0m
Dividends paid———−$125.0m−$121.0m−$116.0m−$99.0m−$96.0m−$100.0m−$92.0m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue−$6.37bn$12.16bn$3.11bn$3.09bn$3.13bn$3.16bn$3.27bn$3.09bn
Operating income−$975.0m$1.64bn$442.0m$243.0m$512.0m$260.0m$285.0m−$203.0m
Net income$689.0m−$610.0m$110.0m$130.0m$282.0m−$13.0m−$70.0m−$391.0m
Diluted earnings per share5.07-4.490.810.962.09-0.10-0.53-2.96
Cash from operations$87.0m−$297.0m$266.0m$69.0m$88.0m$120.0m$216.0m$67.0m
Capital spending—−$76.0m−$94.0m−$65.0m−$91.0m−$85.0m−$109.0m−$70.0m
Free cash flow—−$373.0m$172.0m$4.0m−$3.0m$35.0m$107.0m−$3.0m
Total assets$12.18bn$13.18bn$13.20bn$13.24bn$13.64bn$13.89bn$14.05bn$13.90bn
Cash and short-term investments$149.0m$712.0m$260.0m$123.0m$456.0m$431.0m$37.0m$33.0m
Debt$126.0m$10.25bn$10.51bn$10.71bn$10.97bn$11.44bn$11.57bn$11.60bn
Shareholders' equity−$844.0m−$1.45bn−$1.39bn−$1.50bn−$1.10bn−$1.92bn−$1.91bn−$1.82bn

Growth per year

Compound annual rate

3 years5 years10 years
Revenue0.7%1.2%-4.3%
Operating income24.8%1.9%1.8%
Net income122.8%-0.1%12.4%

Average margins

Over each period

1 year3 years5 years10 years
Operating margin8.5%7.9%9.1%4.0%
Net margin-0.0%-0.2%0.9%-3.1%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings0.8-0.8-3.17.52.70.6-0.2-0.1-0.1-0.1
Price to sales0.00.00.00.00.10.00.00.00.00.0

Share price return

Finished calendar years

2025202420232022202120202019201820172016
Return6%-4%39%-48%64%158%3%-29%-27%-59%

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years. Last went ex-dividend on 13 Dec 2012.

FY2012
Paid in the year0.25

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.